InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Neumann Mark, Chief Financial Officer. Director active across 1 company, notably Intra-Cellular Therapies, Inc.. In total, 21 filings have been logged. Breakdown: 0 buy · 3 sells. Total volume traded: €1.1m. Activity tracked since 8 April 2022. The latest transaction was filed on 2 April 2025 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Neumann Mark
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations21 total
52,811 shares@ US$132.0059.7% of flowCommon StockSEC:0000950170-25-049627:0
13,133 sharesCommon StockSEC:0000950170-25-036592:0
8,742 sharesCommon StockSEC:0000950170-25-032585:0
11,017 shares0Common StockSEC:0000950170-25-013762:0
18,714 shares@ US$36.895.9% of flowCommon StockSEC:0000950170-24-099258:0
8,636 shares@ US$66.374.9% of flowCommon StockSEC:0000950170-24-029580:0
13,132 sharesCommon StockSEC:0000950170-24-028823:0
7,907 sharesCommon StockSEC:0000950170-24-021564:0
11,860 shares0Common StockSEC:0000950170-24-011394:0
26,754 shares@ US$23.945.6% of flowCommon StockSEC:0001209191-23-054726:0
55,300 shares@ US$18.598.7% of flowCommon StockSEC:0001209191-23-045229:0
5,421 shares@ US$54.862.6% of flowCommon StockSEC:0001209191-23-021627:0
16,708 shares0Common StockSEC:0001209191-23-018286:0
7,241 shares@ US$50.013.2% of flowCommon StockSEC:0001209191-23-016024:0
7,906 sharesCommon StockSEC:0001209191-23-013442:0
11,139 sharesCommon StockSEC:0001209191-23-012001:0
86,348 shares@ US$12.739.5% of flowCommon StockSEC:0001209191-22-023901:0
7,906 sharesCommon StockSEC:0001209191-22-013359:0
11,139 sharesCommon StockSEC:0001209191-22-012394:0
20,948 sharesCommon StockSEC:0001209191-22-002991:0
13,448 sharesCommon StockSEC:0001209191-21-060907:0
21 of 21 declarations
About Neumann Mark
Neumann Mark is Directeur Financier. He has made 21 filings in total, and across the 21 most recent filings held, sales amount to EUR 7532951 between 2021-10-19 and 2025-04-02, with Levée d'options as the most frequent transaction nature. His filings concern Intra-Cellular Therapies, Inc., and the largest listed transaction is a sale of EUR 6390363.346155712 on 2025-04-02.
